美股A股
StockGist
Back
8-K2026-05-14· qwen-plus

MTEX · Mannatech, Incorporated

0001437749-26-017056

SEC filing

Summary

Mannatech reported a first-quarter 2026 net income of $0.95 million ($0.49 diluted EPS), reversing a $1.53 million net loss in Q1 2025, driven by higher gross margin, lower selling and administrative expenses, and improved operational performance despite a $1.6 million decline in GAAP net sales to $24.9 million.

Key takeaways

Full analysis

Mannatech’s Q1 2026 results reflect a meaningful operational turnaround: the company shifted from a $1.53 million net loss in Q1 2025 to $0.95 million net income, its first quarterly profit in at least two years. This reversal was driven by three interrelated improvements—higher gross margin (75.7% vs. 74.3%), lower selling and administrative expenses ($9.3M vs. $10.0M), and reduced commissions and incentives ($9.8M vs. $10.6M)—which collectively narrowed the operating loss from $0.8M to $0.2M. Notably, the improvement occurred despite a $1.6M (6.0%) GAAP net sales decline, with constant-dollar sales falling $2.2M (8.1%), suggesting persistent top-line pressure unrelated to foreign exchange. Management attributes part of the sales decline to macroeconomic headwinds, including trade policy shifts and tariffs, which may affect future cost structure and profitability. The network contraction—down 15.6% in new and continuing associate/customer positions to ~111,000—reinforces concerns about distributor engagement and organic growth sustainability. While cash increased $0.8M to $7.0M, balance sheet leverage remains elevated: total liabilities ($35.4M) exceed total assets ($29.9M), resulting in negative shareholders’ equity of ($5.6M). The press release includes no forward-looking guidance, only cautionary forward-looking statements regarding risks related to recruitment, competition, regulation, and international expansion. Investors should view the profitability inflection as encouraging but provisional, pending evidence of stabilized or growing top-line momentum and network health.